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Background: Intracranial-pressure (ICP) monitoring is considered standard care for severe traumatic brain injury and
is used frequently, but the efficacy of treatment based on monitoring in patients with hemorrhagic stroke has not
been rigorously assessed. In this study, we investigated the clinical value of ICP monitoring in patients with
hemorrhagic stroke.
Methods: We conducted a randomized, unblinded, controlled trial in which 90 patients with hemorrhagic stroke
were randomly assigned to ICP monitoring or a control group. The primary outcome was a composite of incidence
rate of hematoma enlargement and secondary brain herniation. The secondary outcome was neurological status
assessed using the Glasgow Outcome Scale scores at 6 months post-onset. Characteristics of the patients at
baseline and outcome measurements were also compared between the two groups.
Results: There was no significant between-group difference in the incidence of hematoma enlargement (control
group, 38.6% vs. ICP monitoring group, 32.6%; P > 0.05). The incidence rate of secondary brain herniation in the ICP
monitoring group was significantly lower compared with the control group (10.9% vs. 20.5%, P = 0.04). Six-month
mortality was 6.5% in the ICP group and 9.1% in the control group (P < 0.05), and neurological outcome was better
in the ICP group compared with the control group (P < 0.05).
Conclusion: The dynamic ICP value may be more sensitive and effective in preventing secondary brain herniation
in patients with hemorrhagic stroke compared with guidance directed by clinical signs and radiological indicators.
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Intracranial pressure (ICP) monitoring is widely used as
standard care for patients with severe traumatic brain
injury, but its use in patients with hemorrhagic stroke
has not been rigorously assessed. Currently, hemorrhagic
stroke has the highest mortality rate of all stroke subtypes
[1]. Hematoma growth is a principal cause of early neuro-
logical deterioration [2]. Thus, early warning of hematoma
enlargement is critical in clinical settings.
Increased ICP following cerebral hemorrhage is associ-
ated with secondary hematoma enlargement, brain hernia-
tion, and worse neurological outcomes. The evaluation of* Correspondence: 179058882@qq.com
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unless otherwise stated.ICP can be obtained through several methods including
direct detection and indirect assessment according to clin-
ical signs and radiological characteristics. Traditionally,
deteriorating clinical signs should prompt a repeat com-
puted tomography (CT) scan to assess the need for urgent
neurosurgical intervention. However, this is likely to be
delayed by late or inaccurate observation of patients in
clinical settings. Direct ICP monitoring allows early de-
tection of pressure changes and can guide treatment of
elevated ICP.
Few studies have investigated the relationship between
ICP elevation and neurological deterioration in hemorrhagic
stroke, and whether ICP monitoring is useful to indicate
early hematoma enlargement or brain herniation [1].
Thus, in this study, we investigated the potential effects
of continuous ICP monitoring in the warning of hematomatd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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hemorrhagic stroke.Methods
Study design and patients
This study was a parallel-group trial with randomized as-
signment to the ICP monitoring group or control group.
Patients with hemorrhagic stroke were admitted to the
Neurosurgical Department of the Shanghai Pudong New
Area People’s Hospital from January 2010 to December
2012. The inclusion criteria in this study were as follows:
(1) The aetiology for hemorrhages was hypertension; (2) All
patients did not have initial intraventricular hemorrhage
and brain herniation when admitted; (3) All patients were
enrolled within 6 h of post-hemorrhagic stroke. We ex-
cluded patients with previous cerebrovascular diseases
or taking oral anticoagulants. Three-dimensional CT
and magnetic resonance imaging scans were used to
rule out aneurysms, arteriovenous malformations, and
amyloid hemorrhages.Group assignments and procedures
Randomization sequences were computer generated
by Excel random number generation. Patients in the
ICP group underwent ICP monitoring implantation under
general anesthesia (Codman, Johnson & Johnson, Raynham,
MA, USA). The ICP sensor was inserted into the anter-
ior horn of the lateral ventricle, allowing for drainage of
cerebral spinal fluid (CSF) [3]. The contralateral side
was chosen for external ventricular drain placement to
avoid hematomas. Ventricular ICP measurement is con-
sidered a ‘gold-standard’ method for assessing elevations
in global ICP [4]. Both groups were given routine med-
ical therapies including hemostasis, reduction of blood
pressure, and diuretic or mannitol treatment according
to established guidelines [1,5]. Neurological exams in-
cluding the pupil test, extremity test and reflex test were
conducted in both groups every 8 h during the first
three days, and a repeat CT scan was scheduled 24 h after
stroke, and the neurological assessment was performed
every 24 h thereafter only if no clinical deterioration was
noted. This protocol is designed to balance the evaluation
frequency between the ICP monitoring group and control
group.
When the ICP was > 25 mmHg, mannitol or a diuretic
was immediately administered and CSF was drained to
lower the ICP; otherwise, the diuretic was given every 8 h/
day to maintain the osmotic pressure between 280 and
320 osmol/L. If the ICP was still > 30 mmHg for 15 min
or longer, then the patient was required to undergo CT
scanning to assess the progression of hematoma. In the
control group, the dosage of mannitol was based on
neurological signs and physiological measurements.Outcomes
The primary outcome, assessed within 1 month after study
onset, was a composite of incidence rate of hematoma
enlargement and brain herniation. Hematoma expansion
was diagnosed if a patient’s repeat CT scan was read as
worsening because of new lesions or an increase in the
original volume of abnormalities (≥25% increase in the
lesion on the first post-injury CT scan) [6]. The volume of
hematoma was calculated using the traditional Approxi-
mate Bayesian Compressive Sensing (ABCS) method [7].
Brain herniation is shown by a lowered level of conscious-
ness with a Glasgow Coma Scale (GCS) score of 3–8, plus
one or both pupils may be dilated and fail to constrict
in response to light [8], which is confirmed by a head
CT scan. The secondary outcome was neurological sta-
tus assessed using the Glasgow outcome scale (GOS) at
6 months post-onset. The GOS is a five-point scale with
a range of 1 (dead) to 5 (good recovery). The GOS was
determined through an outpatient follow-up or a struc-
tured telephone interview by staff blinded to patient
grouping.Protocol approval and patient consent
The study protocol was approved by the local ethics
committee of the Shanghai Pudong New Area People’s
Hospital. For study registration, written informed consent
was obtained before the study began from patient’s rela-
tives. For follow-up by telephone interview, verbal in-
formed consent was also obtained.Statistical analysis
All statistical analyses were performed using SPSS
version 20.0 (SPSS, Inc., Chicago, IL, USA). P < 0.05 was
considered statistically significant. Characteristics of the
ICP group and control group were compared using a
Chi-square test or unpaired t-test in the case of ordinal
variables. The incidence rates of hematoma enlargement
and brain herniation were compared using the Chi-square
test and Fisher’s exact test, and GOS scores were com-
pared using the Wilcoxon rank test.Results
Patient demographics and early injury characteristics
A total of 90 patients with hemorrhagic stroke were en-
rolled in our study, including 46 patients in the ICP
monitoring group and 44 patients in the control group.
Detailed demographics of patients are shown in Table 1.
Baseline conditions such as age, gender, admitted GCS,
time from onset to admission, systolic blood pressure,
location of hematoma, and hematoma volume were not
significantly different between the two groups (P > 0.05).






Patient numbers 46 44
Age (yrs) 42.5 (20–65) 43 (18–68) 0.12
Gender, male/female 34/12 29/15 0.49
GCS at admission 10 ± 1 11 ± 1 0.92
Time between onset and
admission (hours)
2.46 ± 0.58 2.30 ± 0.81 0.58
Systolic pressure
(mmHg)






19 ± 6 21 ± 4 0.67
Table 3 6-month GOS in ICP and control group
Group Cases GOS P
5 4 3 2 1
Control 44 14 9 9 8 4 Z = 7.133
ICP monitoring 46 28 8 4 3 3 P = 0.03
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herniation post-onset
Hematoma enlargement was found in most patients
3–10 days post-onset. The incidence of hematoma
enlargement in the ICP monitoring group (32.6%) was
similar to the control group (38.6%) (χ [2] = 4.717, P = 0.76)
(Table 2). However, only 10.9% of patients with ICP
monitoring developed secondary brain herniation;
while around 20.5% of patients without ICP monitoring
deteriorated into brain herniation status (P = 0.04) (Table 2).
All enrolled patients with brain herniation underwent acute
evacuation of hematoma. There were no complications
associated with ICP monitoring including hemorrhage
or infection in the ICP monitoring group.
Neurological outcome
Statistical analysis showed that 6-month mortality was
6.5% in the ICP monitoring group and 9.1% in the control
group (P = 0.04). Furthermore, neurological outcome was
significantly different between the two groups (Z = 7.133,
P = 0.03) (Table 3).
Discussion
In this prospective study, compared with the control
group, the ICP monitoring group experienced a lower
incidence of secondary brain herniation within 1-month
post-onset. In addition, patients with ICP monitoring
had better neurological outcomes compared with thoseTable 2 Incidence of hematoma enlargement and
secondary brain herniation in ICP and control groups
Cases
Group Hematoma enlargement Brain herniation
Control 44 17 9
ICP monitoring 46 15 5
P 0.76 0.04without ICP monitoring. This may indicate the superiority
of clinical management guided by ICP monitoring over
guidance by neurological examination and serial CT
imaging in patients with hemorrhagic stroke.
The expansion of hypertensive intracerebral hemorrhage
occurs earlier, and brain edema emerges more gradually.
An enlarged hematoma and edema may result in a reduc-
tion in intracranial volume reserve followed by a rise in
ICP, and further cause dysfunction of cerebral vascular
auto-regulation and decreased cerebral perfusion. If not
promptly treated, this can lead to severe deterioration.
Thus, early amelioration of increased intracranial pressure
is critically important for patients with hemorrhagic
stroke. However, there are few studies regarding the rela-
tionship between the dynamic change in ICP and neuro-
logical outcome, and correlation of ICP monitoring with
hematoma enlargement and secondary brain herniation.
A sudden increase and fluctuation of blood pressure
can easily lead to further bleeding with the formation of
an enlarged hematoma, which will also cause increased
ICP. In such circumstances, ICP monitoring allows early
warning of these pathological changes. During clinical
practice, if ICP is > 30 mmHg and lasts at least 15 min,
then the patient will undergo immediate CSF drainage,
followed by an urgent CT scan to detect hematoma en-
largement. After evacuation of the hematoma, the ICP
in most patients will decrease to < 20 mmHg, which is
an important predictor of clinical recovery.
Although ICP monitoring cannot directly decrease the
incidence of brain herniation, patients with ICP monitor-
ing seem to undergo more intensive care from medical
staff. In addition, pharmaceutical therapies such as dehy-
dration, anti-hypertension, and hemostatic control can be
adjusted more precisely and timely according to the dy-
namic ICP values compared with those indicated by
clinical signs and radiological findings.
Finally, some limitations of our study must be men-
tioned. First, some studies have suggested that ICP moni-
toring is associated with an increased chance of developing
iatrogenic complications, such as intracranial infection
and ventricular hemorrhage [9], but these signs were
not observed in our study, especially with regard to
intraventricular hemorrhage. Furthermore, this was a
single-center report. The validity of our results in a
larger population with hemorrhagic stroke needs to
be confirmed in future prospective, multicenter studies.
Last, ICP monitoring is much more beneficial in patients
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required to compare the effects of ICP monitoring
between patients with intracerebral hemorrhage and
intraventricular hemorrhage.
Conclusion
There are many studies supporting the use of ICP moni-
toring in patients with traumatic brain injury, but few have
reliably evaluated its effect in patients with hemorrhagic
stroke. In this randomized controlled study, we found a
lower incidence rate of secondary brain herniation in pa-
tients with ICP monitoring. Furthermore, these patients
had better neurological outcomes compared with those
without ICP monitoring. Although our results demon-
strate the superiority of treatment based on ICP monitor-
ing over treatment guided by neurological testing and
serial CT imaging in improving long-term neurological
recovery, the precise selection of candidates for ICP mon-
itoring and long-term follow-up need to be validated in
future multicenter, randomized controlled studies.
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